ALKERMES | ALKS - 流动资产

股票价格

27.73

每天变化

0.09 0.33%

每月一次

-15.71%

每年

-18.51%

Q1 预测

27.77

金融业

USD

USD 2.49B

现金及等价物

USD 388.57M

USD 46.21M

USD 1.93B

USD 543.44M

USD 71.6M

股息收益率

0

USD -10.95M

USD 100.31M

1.8K

EPS每股收益

USD 0.29

股本和储备

USD 1.82B

USD 338.34M

债务利息支出

USD 12.28M

USD 11.94M

USD 285.82M

USD 4.47B

USD 49.34M

USD 326.44M

USD -10.95M

普通股股本

USD 165.61M

19.54

USD 100.74M

USD 384.5M

销售和管理费用

USD 187.2M

USD 196.63M

贸易债权人

USD 107.95M

应收帐款人

USD 334.03M

	流动资产	更改		日
AbbVie	USD 29.06B		523M	2025-12
Acadia Pharmaceuticals	USD 1.06B		14.31M	2025-12
ALKERMES	USD 1.93B		187.5M	2025-12
Amgen	USD 29.06B		1.17B	2025-12
Biogen	USD 8.97B		37.5M	2025-12
BioMarin Pharmaceutical	USD 3.95B		98.95M	2025-12
Bristol-Myers Squibb	USD 35.63B		2.41B	2025-09
Coherus Biosciences	USD 206.71M		254.25M	2025-12
Eli Lilly	USD 55.63B		6.44B	2025-12
Gilead Sciences	USD 19.89B		1.05B	2025-12
Heron Therapeutics	USD 229.4M		18.48M	2025-09
Ionis Pharmaceuticals	USD 2.99B		471.01M	2025-12
J&J	USD 55.62B		1.01B	2025-12
Malin Corporation	EUR 62.6M		26.7M	2024-12
Merck	USD 47.56B		10.49B	2025-09
Minerva Neurosciences	USD 83.1M		70.08M	2025-12
Nektar Therapeutics	USD 281.36M		94.79M	2025-09
Neurocrine Biosciences	USD 2.52B		364.3M	2025-12
Otsuka Holdings	JPY 1.62T		113.12B	2025-12
Ovoca Bio	EUR 4.96M		2.06M	2022-06
Pfizer	USD 46.92B		3.22B	2025-09
Regeneron Pharmaceuticals	USD 18.02B		41.2M	2025-12
Vertex Pharmaceuticals	USD 11.2B		631.4M	2025-12